top of page
MEMBERS
Yebeen Yu, B.S.
FORMER LAB MEMBER
AFFILIATION
-
DEPARTMENT
-
EDUCATION
-
CONTACT
-
PUBLICATIONS
• Choi W, Kim YH, Woo SM, Yu Y, et al. Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients. Cancer Res Treat. 2023 Oct;55(4):1077-1086. doi: 10.4143/crt.2022.1630.
AWARDS
• Best Poster Award, Korean Cancer Association (KCA), Jun 2023 (Title: Ovarian cancer patient-derived organoids recapitulate the clinical response of the patient)
• Best Oral Presentation Award, Asian Oncology Society (AOS) - Korean Cancer Association (KCA), Jun 2022 (Title: Established patient-derived organoids using ascites fluid or pleural effusion in cancer patients)
PRESENTATIONS
• Ovarian cancer patient-derived organoids recapitulate the clinical response of the patient. Poster presented at: Korean Cancer Association (KCA); Jun 15-16, 2023; Seoul, Korea. (Awarded: Best Poster Award)
• Patient-Derived Organoids (PDOs) Hub of National Cancer Center, Korea: Pre-clinical Model for Drug Screening. Poster presented at: Korean Cancer Association (KCA); Jun 15-16, 2023; Seoul, Korea.
• Ovarian cancer patient-derived organoids and tumor xenografts as preclinical models for precision medicine. Poster presented at: American Association for Cancer Research (AACR); Apr 14-19, 2023; Orlando, USA.
• Patient-Derived Organoids (PDOs) Hub of National Cancer Center, Korea: Pre-clinical Model for Drug Screening. Poster presented at: American Association for Cancer Research (AACR); Apr 14-19, 2023; Orlando, USA.
• Established patient-derived organoids using ascites fluid or pleural effusion in cancer patients. Oral Presented at: Asian Oncology Society (AOS) and Korean Cancer Association (KCA); June 16-18, 2022; Seoul, Korea. (Awarded: Best Oral Presentation Award)
bottom of page